BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20873400)

  • 1. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
    Strand A; Böttiger D; Gever LN; Wheeler W
    Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trial.
    Hull CM; Harmenberg J; Arlander E; Aoki F; Bring J; Darpö B; Levin MJ; Tyring S; Spruance SL;
    J Am Acad Dermatol; 2011 Apr; 64(4):696.e1-11. PubMed ID: 20851499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
    Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
    Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.
    Hull CM; Levin MJ; Tyring SK; Spruance SL
    Antimicrob Agents Chemother; 2014; 58(3):1273-8. PubMed ID: 24342632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for prevention of herpes simplex labialis (cold sores on the lips).
    Chi CC; Wang SH; Delamere FM; Wojnarowska F; Peters MC; Kanjirath PP
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010095. PubMed ID: 26252373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
    Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
    Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
    J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial.
    Lin L; Chen XS; Cui PG; Wang JB; Guo ZP; Lu NZ; Bi ZG; Jia H; Yang XY;
    J Dermatolog Treat; 2002 Jun; 13(2):67-72. PubMed ID: 12060504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silica gel is as effective as acyclovir cream in patients with recurrent herpes labialis: results of a randomized, open-label trial.
    Zschocke I; Reich C; Zielke A; Reitmeier N; Reich K
    J Dermatolog Treat; 2008; 19(3):176-81. PubMed ID: 18569274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes Labialis: An Update.
    Leung AKC; Barankin B
    Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent herpes simplex labialis: selected therapeutic options.
    Raborn GW; Grace MG
    J Can Dent Assoc; 2003 Sep; 69(8):498-503. PubMed ID: 12954137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis.
    Karlsmark T; Goodman JJ; Drouault Y; Lufrano L; Pledger GW;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1184-92. PubMed ID: 18462303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.
    Sacks SL; Thisted RA; Jones TM; Barbarash RA; Mikolich DJ; Ruoff GE; Jorizzo JL; Gunnill LB; Katz DH; Khalil MH; Morrow PR; Yakatan GJ; Pope LE; Berg JE;
    J Am Acad Dermatol; 2001 Aug; 45(2):222-30. PubMed ID: 11464183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical acyclovir in the treatment of recurrent herpes simplex virus infections.
    Kinghorn GR
    Scand J Infect Dis Suppl; 1985; 47():58-62. PubMed ID: 3912972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
    McKeough MB; Spruance SL
    Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.